{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:22:04Z","timestamp":1780633324696,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00108-022-01398-6","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T11:21:14Z","timestamp":1662117674000},"page":"1028-1035","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Darm-Leber-Achse \u2013 wie der Darm die Leber krank macht","The gut\u2013liver axis: how the gut promotes liver disease"],"prefix":"10.1007","volume":"63","author":[{"given":"M\u00fcnevver","family":"Demir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"issue":"7","key":"1398_CR1","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/liv.14899","volume":"41","author":"S Lang","year":"2021","unstructured":"Lang\u00a0S, Martin\u00a0A, Zhang\u00a0X, Farowski\u00a0F, Wisplinghoff\u00a0H, Vehreschild MJGT et al (2021) Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy-proven non-alcoholic fatty liver disease. Liver Int 41(7):1576\u20131591","journal-title":"Liver Int"},{"issue":"6","key":"1398_CR2","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","volume":"146","author":"B Schnabl","year":"2014","unstructured":"Schnabl\u00a0B, Brenner\u00a0DA (2014) Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146(6):1513\u20131524","journal-title":"Gastroenterology"},{"issue":"11","key":"1398_CR3","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1111\/jgh.15071","volume":"35","author":"M Demir","year":"2020","unstructured":"Demir\u00a0M, Lang\u00a0S, Martin\u00a0A, Farowski\u00a0F, Wisplinghoff\u00a0H, Vehreschild\u00a0M et al (2020) Phenotyping non-alcoholic fatty liver disease by the gut microbiota: ready for prime time? J\u00a0Gastroenterol Hepatol 35(11):1969\u20131977","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"1398_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","volume":"17","author":"J Aron-Wisnewsky","year":"2020","unstructured":"Aron-Wisnewsky\u00a0J, Vigliotti\u00a0C, Witjes\u00a0J, Le\u00a0P, Holleboom\u00a0AG, Verheij\u00a0J et al (2020) Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat Rev Gastroenterol Hepatol 17(5):279\u2013297","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7783","key":"1398_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","volume":"575","author":"Y Duan","year":"2019","unstructured":"Duan\u00a0Y, Llorente\u00a0C, Lang\u00a0S, Brandl\u00a0K, Chu\u00a0H, Jiang\u00a0L et\u00a0al (2019) Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature 575(7783):505\u2013511","journal-title":"Nature"},{"issue":"2","key":"1398_CR6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/hep.30832","volume":"71","author":"S Lang","year":"2020","unstructured":"Lang\u00a0S, Duan\u00a0Y, Liu\u00a0J, Torralba\u00a0MG, Kuelbs\u00a0C, Ventura-Cots\u00a0M et al (2020) Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis. Hepatology 71(2):522\u2013538","journal-title":"Hepatology"},{"issue":"4","key":"1398_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jhep.2021.11.029","volume":"76","author":"M Demir","year":"2022","unstructured":"Demir\u00a0M, Lang\u00a0S, Hartmann\u00a0P, Duan\u00a0Y, Martin\u00a0A, Miyamoto\u00a0Y et al (2022) The fecal mycobiome in non-alcoholic fatty liver disease. J\u00a0Hepatol 76(4):788\u2013799","journal-title":"J Hepatol"},{"issue":"5","key":"1398_CR8","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1053\/j.gastro.2020.07.005","volume":"159","author":"S Lang","year":"2020","unstructured":"Lang\u00a0S, Demir\u00a0M, Martin\u00a0A, Jiang\u00a0L, Zhang\u00a0X, Duan\u00a0Y et\u00a0al (2020) Intestinal virome signature associated with severity of nonalcoholic fatty liver disease. Gastroenterology 159(5):1839\u20131852","journal-title":"Gastroenterology"},{"issue":"42","key":"1398_CR9","doi-asserted-by":"publisher","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","volume":"111","author":"S Leclercq","year":"2014","unstructured":"Leclercq\u00a0S, Matamoros\u00a0S, Cani\u00a0PD, Neyrinck\u00a0AM, Jamar\u00a0F, Starkel\u00a0P et al (2014) Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S\u00a0A 111(42):E4485\u201393","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1398_CR10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","volume":"30","author":"J Yuan","year":"2019","unstructured":"Yuan\u00a0J, Chen\u00a0C, Cui\u00a0J, Lu\u00a0J, Yan\u00a0C, Wei\u00a0X et al (2019) Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae. Cell Metab 30(4):675\u2013688","journal-title":"Cell Metab"},{"issue":"2","key":"1398_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","volume":"57","author":"L Zhu","year":"2013","unstructured":"Zhu\u00a0L, Baker\u00a0SS, Gill\u00a0C, Liu\u00a0W, Alkhouri\u00a0R, Baker\u00a0RD et\u00a0al (2013) Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a\u00a0connection between endogenous alcohol and NASH. Hepatology 57(2):601\u2013609","journal-title":"Hepatology"},{"issue":"11","key":"1398_CR12","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1136\/gutjnl-2015-309957","volume":"65","author":"F De Filippis","year":"2016","unstructured":"De Filippis\u00a0F, Pellegrini\u00a0N, Vannini\u00a0L, Jeffery\u00a0IB, La Storia\u00a0A, Laghi\u00a0L et al (2016) High-level adherence to a\u00a0Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut 65(11):1812\u20131821","journal-title":"Gut"},{"issue":"2","key":"1398_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/apt.13248","volume":"42","author":"HL Simpson","year":"2015","unstructured":"Simpson\u00a0HL, Campbell\u00a0BJ (2015) Review article: dietary fibre-microbiota interactions. Aliment Pharmacol Ther 42(2):158\u2013179","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"1398_CR14","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G den Besten","year":"2013","unstructured":"den Besten\u00a0G, van Eunen\u00a0K, Groen\u00a0AK, Venema\u00a0K, Reijngoud\u00a0DJ, Bakker\u00a0BM (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J\u00a0Lipid Res 54(9):2325\u20132340","journal-title":"J Lipid Res"},{"issue":"7","key":"1398_CR15","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.2337\/db14-1213","volume":"64","author":"G den Besten","year":"2015","unstructured":"den Besten\u00a0G, Bleeker\u00a0A, Gerding\u00a0A, van Eunen\u00a0K, Havinga\u00a0R, van Dijk\u00a0TH et al (2015) Short-chain fatty acids protect against high-fat diet-induced obesity via a\u00a0PPARgamma-dependent switch from lipogenesis to fat oxidation. Diabetes 64(7):2398\u20132408","journal-title":"Diabetes"},{"issue":"7122","key":"1398_CR16","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh\u00a0PJ, Ley\u00a0RE, Mahowald\u00a0MA, Magrini\u00a0V, Mardis\u00a0ER, Gordon\u00a0JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027\u20131031","journal-title":"Nature"},{"issue":"9","key":"1398_CR17","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1194\/jlr.R024794","volume":"53","author":"G Porez","year":"2012","unstructured":"Porez\u00a0G, Prawitt\u00a0J, Gross\u00a0B, Staels\u00a0B (2012) Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J\u00a0Lipid Res 53(9):1723\u20131737","journal-title":"J Lipid Res"},{"issue":"1","key":"1398_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40168-021-01101-1","volume":"9","author":"DV Guzior","year":"2021","unstructured":"Guzior\u00a0DV, Quinn\u00a0RA (2021) Review: microbial transformations of human bile acids. Microbiome 9(1):140","journal-title":"Microbiome"},{"issue":"48","key":"1398_CR19","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.3748\/wjg.v26.i48.7603","volume":"26","author":"X Qi","year":"2020","unstructured":"Qi\u00a0X, Yang\u00a0M, Stenberg\u00a0J, Dey\u00a0R, Fogwe\u00a0L, Alam\u00a0MS et\u00a0al (2020) Gut microbiota mediated molecular events and therapy in liver diseases. World J Gastroenterol 26(48):7603\u20137618","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1398_CR20","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/hep.30690","volume":"70","author":"JS Bajaj","year":"2019","unstructured":"Bajaj\u00a0JS, Salzman\u00a0NH, Acharya\u00a0C, Sterling\u00a0RK, White\u00a0MB, Gavis\u00a0EA et al (2019) Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial. Hepatology 70(5):1690\u20131703","journal-title":"Hepatology"},{"issue":"3","key":"1398_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s12664-018-0859-4","volume":"37","author":"CA Philips","year":"2018","unstructured":"Philips\u00a0CA, Phadke\u00a0N, Ganesan\u00a0K, Ranade\u00a0S, Augustine\u00a0P (2018) Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis. Indian J Gastroenterol 37(3):215\u2013225","journal-title":"Indian J Gastroenterol"},{"issue":"21","key":"1398_CR22","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp\u00a0Z, Bloom\u00a0PP, Torres Soto\u00a0M, Mansour\u00a0MK, Sater\u00a0MRA, Huntley\u00a0MH et al (2019) Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N\u00a0Engl J Med 381(21):2043\u20132050","journal-title":"N Engl J Med"},{"key":"1398_CR23","doi-asserted-by":"publisher","first-page":"572912","DOI":"10.3389\/fcimb.2020.572912","volume":"10","author":"J Ramirez","year":"2020","unstructured":"Ramirez\u00a0J, Guarner\u00a0F, Bustos Fernandez\u00a0L, Maruy\u00a0A, Sdepanian\u00a0VL, Cohen\u00a0H (2020) Antibiotics as major disruptors of gut microbiota. Front Cell Infect Microbiol 10:572912","journal-title":"Front Cell Infect Microbiol"},{"key":"1398_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.06.001","author":"European Association for the Study of the Liver","year":"2022","unstructured":"European Association for the Study of the Liver (2022) EASL Clinical Practice Guidelines on the management of hepatic encephalopathy. J\u00a0Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2022.06.001","journal-title":"J Hepatol"},{"issue":"3","key":"1398_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jhepr.2019.04.004","volume":"1","author":"KJ Schwenger","year":"2019","unstructured":"Schwenger\u00a0KJ, Clermont-Dejean\u00a0N, Allard\u00a0JP (2019) The role of the gut microbiome in chronic liver disease: the clinical evidence revised. JHEP Rep 1(3):214\u2013226","journal-title":"JHEP Rep"},{"issue":"1","key":"1398_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/ajcn\/nqz042","volume":"110","author":"SR Sharpton","year":"2019","unstructured":"Sharpton\u00a0SR, Maraj\u00a0B, Harding-Theobald\u00a0E, Vittinghoff\u00a0E, Terrault\u00a0NA (2019) Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a\u00a0systematic review, meta-analysis, and meta-regression. Am J Clin Nutr 110(1):139\u2013149","journal-title":"Am J Clin Nutr"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01398-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-022-01398-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01398-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T09:06:48Z","timestamp":1664183208000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-022-01398-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1398"],"URL":"https:\/\/doi.org\/10.1007\/s00108-022-01398-6","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"22 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Demir und F.\u00a0Tacke geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}